ExodusPoint Capital Management »

Supernus Pharmaceuticals shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $11M 229k 49.70
2023-03-31 $1.7M 47k 36.23
2022-03-31 $1.1M 33k 32.33
2021-12-31 $1.0M 36k 29.16

More positions owned by ExodusPoint Capital Management

NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Broadcom Put Option (AVGO)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp Call Option (MDY)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Wal-Mart Stores (WMT)
Tesla Motors Put Option (TSLA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Meta Platforms Cl A Call Option (META)
Electronic Arts (EA)
Evergy (EVRG)
Boeing Company (BA)

View all positions for ExodusPoint Capital Management

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Armistice Capital
Dimensional Fund Advisors
Point72 Asset Management
State Street Corporation
Renaissance Technologies
Geode Capital Management
Loomis, Sayles and
Citadel Advisors
Stephens Investment Management Group
Jennifer Ranahan
D. E. Shaw & Co
Charles Schwab Investment Management
Goldman Sachs Group

View all funds holding Supernus Pharmaceuticals